Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 1 |
2015 | 1 |
2017 | 1 |
2018 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness.
Mol Cancer Res. 2023 Dec 1;21(12):1288-1302. doi: 10.1158/1541-7786.MCR-22-0871.
Mol Cancer Res. 2023.
PMID: 37584671
Blurring Boundaries: Receptor Tyrosine Kinases as functional G Protein-Coupled Receptors.
Crudden C, Shibano T, Song D, Suleymanova N, Girnita A, Girnita L.
Crudden C, et al. Among authors: suleymanova n.
Int Rev Cell Mol Biol. 2018;339:1-40. doi: 10.1016/bs.ircmb.2018.02.006. Epub 2018 Apr 3.
Int Rev Cell Mol Biol. 2018.
PMID: 29776602
Review.
Item in Clipboard
The dichotomy of the Insulin-like growth factor 1 receptor: RTK and GPCR: friend or foe for cancer treatment?
Crudden C, Ilic M, Suleymanova N, Worrall C, Girnita A, Girnita L.
Crudden C, et al. Among authors: suleymanova n.
Growth Horm IGF Res. 2015 Feb;25(1):2-12. doi: 10.1016/j.ghir.2014.10.002. Epub 2014 Oct 28.
Growth Horm IGF Res. 2015.
PMID: 25466906
Review.
Item in Clipboard
Novel mechanisms of regulation of IGF-1R action: functional and therapeutic implications.
Worrall C, Nedelcu D, Serly J, Suleymanova N, Oprea I, Girnita A, Girnita L.
Worrall C, et al. Among authors: suleymanova n.
Pediatr Endocrinol Rev. 2013 Jul;10(4):473-84.
Pediatr Endocrinol Rev. 2013.
PMID: 23957198
Review.
Item in Clipboard
IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.
Song D, Cismas S, Crudden C, Trocme E, Worrall C, Suleymanova N, Lin T, Zheng H, Seregard S, Girnita A, Girnita L.
Song D, et al. Among authors: suleymanova n.
Oncogene. 2022 Jan;41(4):600-611. doi: 10.1038/s41388-021-02111-x. Epub 2021 Nov 17.
Oncogene. 2022.
PMID: 34785779
Item in Clipboard
Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.
Song D, Cismas S, Crudden C, Trocme E, Worrall C, Suleymanova N, Lin T, Zheng H, Seregard S, Girnita A, Girnita L.
Song D, et al. Among authors: suleymanova n.
Oncogene. 2023 Mar;42(11):858. doi: 10.1038/s41388-023-02607-8.
Oncogene. 2023.
PMID: 36759575
No abstract available.
Item in Clipboard
Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation.
Suleymanova N, Crudden C, Worrall C, Dricu A, Girnita A, Girnita L.
Suleymanova N, et al.
Oncotarget. 2017 Jul 17;8(47):82256-82267. doi: 10.18632/oncotarget.19286. eCollection 2017 Oct 10.
Oncotarget. 2017.
PMID: 29137261
Free PMC article.
Item in Clipboard
Cite
Cite